LFCR DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCRGlobeNewsWire • 31m
The Schall Law Firm Encourages Investors To Take Part In A Case Against Lifecore Biomedical Inc For Securities FraudAccesswire • 2h
LFCR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!Accesswire • 3h
Lifecore Biomedical, Inc. Is Being Sued For Securities Law Violations And Affected Shareholders Are Urged To Help The Schall Law FirmAccesswire • Thursday
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifecoreGlobeNewsWire • Thursday
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lifecore Biomedical, Inc. of Class Action Lawsuit and Upcoming Deadlines - LFCRAccesswire • Thursday
LFCR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!Accesswire • Thursday
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and OperationalGlobeNewsWire • Thursday
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR)GlobeNewsWire • Wednesday
The Schall Law Firm Invites Investor Participation In A Securities Fraud Case Against Lifecore Biomedical IncAccesswire • Wednesday
LFCR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • Wednesday
LFCR Deadline: LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud LawsuitPRNewsWire • Tuesday
Faruqi & Faruqi Reminds Lifecore Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 27, 2024 - LFCRPRNewsWire • Tuesday
Lifecore Biomedical, Inc. Is Being Sued For Violating Securities Laws And Impacted Shareholders Should Lend A Hand To The Schall Law FirmAccesswire • Tuesday
LFCR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • Tuesday
LFCR DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCRGlobeNewsWire • Tuesday
LFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitGlobeNewsWire • Monday
A Securities Fraud Case Has Been Filed Against Lifecore Biomedical Inc And The Schall Law Firm Urges Investor ParticipationAccesswire • Monday
LFCR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • Monday
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law FirmPRNewsWire • Monday
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lifecore Biomedical, Inc. of Class Action Lawsuit and Upcoming Deadlines – LFCRAccesswire • 09/15/24
Lifecore Biomedical, Inc. Is Being Sued For Possible Securities Law Violations And Affected Shareholders Are Invited To Contact The Schall Law FirmAccesswire • 09/15/24
LFCR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 09/15/24
The Schall Law Firm Wants Investors With Losses In Lifecore Biomedical Inc To Contribute To A Lawsuit For Securities FraudAccesswire • 09/14/24
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud LawsuitPRNewsWire • 09/13/24